SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?


To: BigKNY3 who wrote (5099)8/23/1998 12:32:00 AM
From: Anthony Wong  Read Replies (1) | Respond to of 9523
 
BigKNY3, and thanks for your great links and reports! The analyst update is invaluable.

Anthony



To: BigKNY3 who wrote (5099)8/23/1998 4:18:00 AM
From: flickerful  Respond to of 9523
 
Big K.

thanks for this week's memories...
and some week, it was, huh.

beyond the everyday
uptick/downtick viagra saga
in the spotlight, we had your basic
greek tragedy unfold on television
[well maybe not exactly unfold]
currencies reeling en masse, and
missile strikes on terrorist strongholds,
russia devaluing/not devaluing, gore gored,
the avengers opening, double witching...
and
dr. sidney meets george soros.

all things considered, PFE handled herself admirably.



To: BigKNY3 who wrote (5099)8/23/1998 8:53:00 AM
From: Anthony Wong  Read Replies (1) | Respond to of 9523
 
08/23 07:56 Euro drug regulators to meet on Viagra approval

LONDON, Aug 23 (Reuters) - European drug regulators are set to meet on Monday afternoon to discuss approval of Viagra, the blockbuster anti-impotence drug from U.S. pharmaceuticals group Pfizer Inc, the company said on Sunday.

Pfizer told Reuters that the meeting was "the last major hurdle" blocking Viagra's sale in Europe and that if the meeting went well, with no serious obstacles raised, European regulators could move to license the drug for sale in Europe within weeks.

The meeting of the European Medicines Evaluation Agency, responsible for clearing new drugs, is due to be held on Monday afternoon and will be attended by government and industry officials from all European Union member states, a spokesman for Pfizer told Reuters.

"It is no secret that the EMEA committee is meeting to review drug application, " said the Pfizer spokesman.

"But this will not be a rubber-stamping job. It is a highly important meeting and the final major hurdle. If the outcome is positive, then they should be able to issue a Europe-wide license to Viagra within a number of weeks."

Viagra has already witnessed a sales bonanza in the U.S., moving quickly to recoup its 350 million pounds development costs.

After its launch there, Viagra became the fastest selling drug in history, with U.S. doctors issuing 3.5 million prescriptions for Viagra since its U.S. approval in March.

moneynet.com@NEWS-P1&Index=0&HeadlineURL=../News/NewsHeadlines.asp&DISABLE_FORM=



To: BigKNY3 who wrote (5099)8/23/1998 10:56:00 AM
From: BigKNY3  Read Replies (3) | Respond to of 9523
 
The Peabody Report: August 22, 1998

The Peabody Report is intended to foster conversation on the PFEr Board. Comments are welcome and encouraged.

Invest only after conducting your own research.

Have PFun!

BigKNY3

__________________________________________________________
Peabody Peak/Valley Status

Peabody Peaks and Valleys since 1/90 (Updated 8/11/98)
www3.techstocks.com

Chart of Peabody Peaks and Valleys with Moving Averages dailystocks.net

Useful PFEr Links
-3 year PFE chart versus the Dow growth. control.bigcharts.com

-6 Month PFE Chart with Da Bollinger Bands Playing 207.95.154.130

-5 Year PFE Price Chart news.com

The Market Environment

-Briefing.com briefing.com

Peabody Model Trend Prediction

Based on historical PFE patterns, the Peabody Model predicts the following trend direction:

A pending Peabody Valley (98.50) was reached on August 11th. Da Model predicts that PFE will head to a new Peabody Peak of 117.19 by next week (August 28, 1998).

Commentary
PFE is still being buffeted by the focus on Viagra and the Asian crisis' impact on the general market.

Since it is based primarily on historical trends and Mr. Peabody "gut-feels", the Peabody Model should always be placed in context of the market environments and anticipated news. As evidenced by the mythical Peabody Portfolio (see section below), the Peabody Model works particularly well for PFE investors with a "buy, hold, and buy more at the Valley" investing strategy.

New or pfuture PFErs could consider investing 50% immediately and investing the
remainder at near Peabody Valleys.

......................................PFE.........................% Chg from...............# Days
.....................................Date.........Price.......Last Price (8/21/98)......From Today
Last Peabody Peak:..... 7/14/98......120.56..........+13.7% ...................-39
Last Peabody Valley*: .. 8/11/98 ......98.50.......... -7.1% .....................-11

* Pending

Forecasted Next Peak.....8/28/98....117.19..........+10.5%................ 6
Potential Peak Strike Price..............108.35............+2.2 %

Forecasted Next Valley................... 96.13.............-9.4%..................
(If Model is Wrong)

______________________________________________
Peabody Short-term PForecasts

Peabody Short-Term PForecast (8/16/98): PFE: 101.19, DJ: 8,425: To determine the PFE short-term direction, you need to predict where the general market is headed. ...Tough job....After a little more pain, I optimistically feel that the 8 year bull will roar again. In the meantime, PFE will be buffeted with any concerns about Viagra specification and irresponsible media stories (ie the WSJ "Freedumb of Information" medical writing staff). Long-term.... international Viagra approvals, improved profit margins sans Medical Technologies, Lipitor, and Celebra submission news.... will relaunch the PFE upbeat trend. Da Gut Feel: Since "If there is evidence on the dress, you must confess", President Clinton will do a "Checkers" speech and bring renewed optimism to the market. PFE will rise to around 105 with the Dow. Growth in Viagra Rxs on Monday would be a big bonus.

Evaluation of Peabody PForecast: Another great call for Mr. P..A big thumbs up.

Peabody PForecast Record (75 weeks): 48-27 (64%)
_________________________________________________________

Peabody Short-Term PForecast (8/23/98): PFE: 106.06, DJ: 8,534: Da Model is optimistically calling for a 10% increase in PFE this week. Seems a little high but it could happen if the bull market moves up 300 points and the EU approves Viagra. Expect a real positive week driven by followers of PFEr George Soros, news from the 8th World Meeting on Impotence Research urolog.nl , and the possible approval of Viagra in the EU . Da Gut Feel: PFE will begin the climb to the Peak with a close above 112.

___________________________________________
Peabody Portfolio
For only the second time in its history, the Portfolio made two purchases in a single week.

Total return:........................................+67.0% PFE @ 106.06
Annualized return:...............................+69.1%
% of Peabody purchases in the black... 87% (20 out of 23)

The Peabody Portfolio consists of 23 PFE purchase recommendations listed on the PFEr Board since August 14, 1996. To date, the Portfolio has purchased 3,900 PFE shares at an average price of $63.47 (only 2.7% off the subsequent next PFE Valleys).
________________________________________
# PFE Shares Purchased:.......... 3,900
Average Price of Purchases:....... $63.47
Total Costs: ...............................$247,550
Total Market Value:.....................$413,400
Total Potential Profit:...................$165,850

Date............#..........Purchase
Purchased...Shares...Price
8/14/96:..... 200 ........$36.38
10/25/96:....200 .........$40.44
12/4/96:......200..........$41.69
12/12/96:.....200.........$40.50
12/16/96:.....200.........$40.44
12/31/96:....200..........$41.50
1/2/97:........200.........$40.94
1/28/97: ......200..........$42.38
2/28/97:.......200...........$45.69
3/24/97:.......200...........$44.88
3/27/97:.......200...........$42.81
3/31/97:........200..........$42.56
8/8/97:..........200..........$55.13
4/16/98:........200...........$97.00
4/27/98:........200...........$113.00
5/7/98:..........200...........$107.50
5/15/98:.........100..........$105.00
5/27/98 :........100 .........$101.75
7/06/98 :........100 .........$106.00
7/29/98 :........100 .........$110.50
8/05/98 :........100 .........$104.00
8/07/98 :........100 .........$102.63
8/11/98..........100..........$100.00
Total:............3,900.........$63.47
____________________________________________
Suggested PFE Buying Levels

The following suggested PFE buying levels are based on The Peabody Model. The aggressive buying price level is used in adding shares to The Peabody Portfolio. However, depending upon market conditions an immediate purchase could be made at any time:

:..................$97 to $101.................................

________________________________________

PFuture Actions That Will Effect PFE Trends

Viagra Rx trends:..................................... Every Monday throughout 1998
News of Viagra adverse reactions
and drug interactions: ...................................Throughout 1998
8th World Meeting on Impotence Research.....August 24-28,1998
FDA Response to Public Citizen Letter...........September 1998
European approval of Viagra:.........................August 24,1998- December, 1998
NDA submission of Celebra...........................1998?
Expedited review of Celebra.........................One month following NDA submission
Initial reports of Viagra international sales.......September-October, 1998
Third Quarter Earnings.....................................October 14, 1998
PFE R&D Meeting........................................October 29, 1998
ACC/AHA Report on Viagra...........................December1998
ED news in the media: ................................Throughout 1998
Japanese approval of Viagra .........................First half, 1999
_______________________________________________
Peabody V-Files

Viagra sales for the second quarter, 1998 were $411 million, the highest recorded sales for a new pharmaceutical product during its first three months on the market.

Analysts estimate that Viagra will have 1998 sales of $0.952 billion, a 39.3% increase over earlier estimates.

............................................1998 Est...1998 Est
...........................................(Billions)....(Billions)..... Comments
NationsBanc........................$1.100.......$0.759...... $.205B (international)
Credit Suisse First Boston.....$1.100.........................$1.7B (1999)
Morgan Stanley....................$1.010..........................$4.8B (2004)
Alex Brown .........................$1.000.......$0.750..... $1.2B (1999)
Deutsche Bank ....................$1.000 ......$0.750..... $1.75B (1999)
Gerard Klauer........................$1.000......$0.300.... $2.9B (2000)
Gruntal ................................$1.000......$1.000.... $8 B peak (2005)
Alex Brown............................$1,000........................$1.2B (1999)
Cowen...................................$0.850........................$5B+ (2002)
Furman Seltz.........................$0.811........................Only $100M in 3rd Qt
Bear Stearns..........................$0.800......$0.600 ......$200M in 3rd Qt
Merrill Lynch...........................$0.750 .....$0625......
Consensus...........................$0.952.......$0.683

____________
PFE Stock Splits

PFE has split three times in the last ten years ( 2/91, 6/95, and 6/97). The Wayback Machine indicates that PFE usually announces a 2-1 split if PFE trade above 80 for 90 consecutive days. In the January, 1998 survey of 22 PFErs, only 43% felt that PFE will split in 1998.

At the PFE Annual Meeting on April 23, 1998, the PFE CEO stated they will consider requesting additional authorized shares from shareholders later this year. Bottom line, a 3-1 PFE split announcement will be made in late 1998 or early 1999. A request for additional authorized shares was apparently not made by the Board on July 23, 1998.